← Eichor
Study identifier: NCT06225245 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Augmenting Rehabilitation Outcomes and Functional Neuroplasticity Using Epidural Stimulation of Cervical Spinal Cord

Condition: Spinal Cord Injuries · Cervical Spinal Cord Injury  ·  Sponsor: The Methodist Hospital Research Institute

PhaseNA
Planned participants12
Who can joinAll sexes, 22 Years to 65 Years
Healthy volunteersYes

About this study

The goal of this study is to investigate the effects of cervical epidural spinal stimulation with upper extremity training. This is an investigational study. The device used for epidural spinal stimulation (ESS) to deliver spinal stimulation is called the CoverEdgeX 32 Surgical Lead system. This device is approved by the Food and Drug Administration (FDA) for the treatment of severe pain and to manage chronic pain when other treatments have not been effective. In this study, the device is considered an investigational device because it is not approved for use in the treatment of spinal cord injury

This description comes directly from the study's public registry record.

Talk to the study team

Jenny Dinh  ·  346-238-4654  ·  jtdinh@houstonmethodist.org

Rachel Markley  ·  713-441-3770  ·  rmarkley@houstonmethodist.org

Always discuss trial participation with your own doctor first.

Locations (1)

The Methodist Hospital Research InstituteHouston, Texas, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06225245